Bradley J Glass
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Bradley J Glass is currently Director at Quest PharmaTech, Inc. and Director at Resverlogix Corp.
starting in 2025.
Formerly, Mr. Glass was General Counsel at Hepalink USA, Inc. Education includes undergraduate studies at Wabash College and graduate studies at Indiana University Maurer School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-08-2025 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| QUEST PHARMATECH INC. | Directeur/Bestuurslid | - |
| RESVERLOGIX CORP. | Directeur/Bestuurslid | 18-11-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Resverlogix Corp.
Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
Quest PharmaTech, Inc.
Quest PharmaTech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops pharmaceutical products for the treatment of cancer | Commercial Services |
Wabash College
Wabash College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University Maurer School of Law
Indiana University Maurer School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau